Home › Compare › LIXTW vs FCPT

LIXTW vs FCPT: Dividend Comparison 2026

LIXTW yields 9049.77% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LIXTW wins by $20628078872155540.00M in total portfolio value
10 years
LIXTW
LIXTW
● Live price
9049.77%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20628078872155540.00M
Annual income
$20,189,225,229,131,710,000,000.00
Full LIXTW calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — LIXTW vs FCPT

📍 LIXTW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIXTWFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIXTW + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
LIXTW pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIXTW
Annual income on $10K today (after 15% tax)
$769,230.77/yr
After 10yr DRIP, annual income (after tax)
$17,160,841,444,761,954,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, LIXTW beats the other by $17,160,841,444,761,954,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIXTW + FCPT for your $10,000?

LIXTW: 50%FCPT: 50%
100% FCPT50/50100% LIXTW
Portfolio after 10yr
$10314039436077770.00M
Annual income
$10,094,612,614,565,855,000,000.00/yr
Blended yield
97.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

LIXTW
No analyst data
Altman Z
-15.6
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIXTW buys
0
FCPT buys
0
No recent congressional trades found for LIXTW or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIXTWFCPT
Forward yield9049.77% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$20628078872155540.00M ✓$49.1K
Annual income after 10y$20,189,225,229,131,710,000,000.00 ✓$5,775.28
Total dividends collected$20598825129197092.00M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: LIXTW vs FCPT ($10,000, DRIP)

YearLIXTW PortfolioLIXTW Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$915,677$904,977.38$11,401$700.92+$904.3K → LIXTW
2$78,425,318$77,445,542.82$13,064$864.84+$78.41M → LIXTW
3$6,282,983,839$6,199,068,749.48$15,051$1,072.48+$6282.97M → LIXTW
4$470,866,355,476$464,143,562,767.87$17,442$1,337.22+$470866.34M → LIXTW
5$33,012,577,055,280$32,508,750,054,920.79$20,340$1,677.08+$33012577.03M → LIXTW
6$2,165,414,967,816,058$2,130,091,510,366,908.20$23,880$2,116.57+$2165414967.79M → LIXTW
7$132,896,851,494,306,460$130,579,857,478,743,280.00$28,241$2,689.36+$132896851494.28M → LIXTW
8$7,631,926,324,796,117,000$7,489,726,693,697,209,000.00$33,660$3,442.07+$7631926324796.08M → LIXTW
9$410,143,591,611,054,950,000$401,977,430,443,523,100,000.00$40,456$4,439.95+$410143591611054.88M → LIXTW
10$20,628,078,872,155,540,000,000$20,189,225,229,131,710,000,000.00$49,063$5,775.28+$20628078872155540.00M → LIXTW

LIXTW vs FCPT: Complete Analysis 2026

LIXTW — Stock

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

Full LIXTW Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this LIXTW vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIXTW vs SCHDLIXTW vs JEPILIXTW vs OLIXTW vs KOLIXTW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.